Heinemeier · Scandinavian journal of medicine & science in sports 2012 · narrative review · n=?

GH/IGF-I axis and matrix adaptation of the musculotendinous tissue to exercise in humans.

Cited 32 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review of human physiological and mechanistic literature without systematic search methodology

PubMed 22429205 · doi:10.1111/j.1600-0838.2012.01459.x · record verified 2026-08-29

What was done

Narrative review summarizing findings from human studies regarding the role of the systemic growth hormone/insulin-like growth factor I (GH/IGF-I) axis and local IGF-I expression in the adaptation of musculotendinous tissue to exercise. The review examines evidence from pathological hyper-GH/IGF-I states, multi-week GH administration trials, and acute local IGF-I injections into connective tissue.

What was found

No numerical data, sample sizes, or effect estimates were reported in the abstract. Qualitatively, elevated GH/IGF-I levels (pathological, systemic GH administration, or local IGF-I injection) were associated with increased collagen expression and synthesis in muscle and tendon connective tissue, an effect described as far more potent than any effect on contractile muscle proteins. GH/IGF-I also increased skeletal muscle satellite cell counts despite no change in myofibrillar protein synthesis. Finally, the authors note there is no direct evidence establishing that age-related musculotendinous decline (sarcopenia and tendon degradation) is caused by reduced GH/IGF-I activity.

Why it matters

The review clarifies that the primary target of GH/IGF-I in human musculoskeletal tissue is connective tissue remodeling and collagen synthesis rather than direct myofibrillar hypertrophy.

Limits

The abstract provides no quantitative data, effect sizes, or study counts. As a narrative review, it lacks systematic search methodology and is vulnerable to selection bias. The discussed associations do not prove a causal role for declining GH/IGF-I in age-related sarcopenia or tendon deterioration.

Cited by